Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than analysts’ expectations.
Revenues surged 61% to $10.13 billion and adjusted earnings moved up to $1.63 per share from $1.18 per share in the second quarter of 2019. On a reported basis, the company posted a loss of $0.04 per share, compared to earnings of $0.87 per share last year.
“Our second quarter results reflect the passion and focus of our employees, who continue to introduce new medicines, support patients with serious diseases and deliver strong results during the COVID-19 pandemic,” said CEO Giovanni Caforio.
BMY shares rose 5% immediately after the earnings announcement during Thursday’s pre-market trading, after closing the previous session higher. The stock has gained 26% in the past 12 months.
Herman Miller Inc. (NASDAQ: MLHR) is one of the few Wall Street firms that managed to take advantage of the opportunities created by the pandemic, after being hit by the
Cognizant Technology Solutions (NASDAQ: CTSH) has been on a buying spree in 2020. The portfolio of the acquisitions that Cognizant made this year is expected to help the company in
After registering a slow recovery in the first half of the week, the markets pared these gains on Thursday and Friday. The weakness witnessed in the latter half of the